AYTU BIOPHARMA, INC Adjustments to Additional Paid in Capital, Warrant Issued
AYTU BIOPHARMA, INC (AYTU) reported Adjustments to Additional Paid in Capital, Warrant Issued of $379.00 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-27.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-05-11
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for the quarter ending 2022-06-30 was $0.00.
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for the quarter ending 2022-03-31 was $379.00K.
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for the quarter ending 2020-12-31 was $1.27M, a 68.27% decline year-over-year.
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $101.54K.
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for fiscal 2022 was $379.00K.
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for fiscal 2020 was $9.72M, a 432.01% increase from fiscal 2019.
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for fiscal 2019 was $1.83M, a 919.39% increase from fiscal 2018.
- AYTU BIOPHARMA, INC adjustments to additional paid in capital, warrant issued for fiscal 2018 was $179.29K, a 69.94% decline from fiscal 2017.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $379.00K derived: sum of 2 quarters · filed 2023-05-11 | $379.00K 10-K · filed 2022-09-27 | |
| 2022-03-31 | $379.00K 10-Q · filed 2023-05-11 | $379.00K 10-Q · filed 2022-05-16 | ||
| 2020-12-31 | $1.27M 10-Q · filed 2021-05-17 | $1.37M derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2020-09-30 | $101.54K 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $9.72M 10-K · filed 2020-10-06 | |||
| 2020-03-31 | $9.72M 10-Q · filed 2020-05-15 | $13.73M derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $4.01M 10-Q · filed 2021-05-17 | |||
| 2019-06-30 | $1.83M 10-K · filed 2020-10-06 | |||
| 2018-12-31 | $1.83M 10-Q · filed 2020-05-15 | |||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $179.29K derived: sum of 2 quarters · filed 2019-09-26 | $179.29K 10-K · filed 2019-09-26 | |
| 2018-03-31 | $179.29K 10-Q · filed 2019-05-14 | $179.29K 10-Q · filed 2018-05-14 | ||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $0.00 derived: sum of 2 quarters · filed 2018-09-06 | $7.06K derived: sum of 3 quarters · filed 2018-09-06 | $596.43K 10-K · filed 2018-09-06 |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $7.06K derived: sum of 2 quarters · filed 2017-05-11 | $596.43K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $7.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $596.43K 10-Q · filed 2017-02-09 | ||
| 2016-09-30 | $589.38K 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |